About this trial
The goal of this pilot randomised trial is to evaluate whether an online psychosocial intervention (Finding My Way-UK) is feasible and acceptable for individuals living with and beyond curatively treated cancer. The main questions it aims to answer are:
1. Is Finding My Way-UK feasible and acceptable for individuals living with and beyond curatively treated cancer? 2. Are there preliminary signals of efficacy in benefit finding and other well-being outcomes (hope, resilience, and subjective well-being)? 3. What is the potential role of information-seeking styles and self-management self-efficacy?
Participants will be randomly assigned to one of two groups:
1. Finding My Way-UK Intervention group: access a four-week, self-guided online program with six modules covering coping with treatment side effects, managing emotions, social support, body image, and post-treatment adjustment. 2. Control group: receive a digital information pack listing national psychological support resources.
All study activities will take place online. Participants will complete questionnaires before the program, after four weeks, and three months later.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with any cancer within the past 12 months;
Cancer is being (or, indeed, was) treated with curative intent;
Aged 16 years or older;
Possess sufficient English proficiency to provide informed consent and use the program;
Disqualifiers
Diagnosis of cancer not being treated with curative intent (for example, metastatic, stage IV, or otherwise advanced-stage disease);
And/Or have a severe comorbidity that may hinder their ability to participate fully (such as being unable to complete study procedures or provide informed consent).
Trial design
Parallel
Treatments tested in this trial
Finding My Way-UK
BehavioralSelf-guided, web-based psychosocial intervention integrating cognitive-behavioural, psychoeducational, and mindfulness-based strategies to support people living with and beyond curatively treated cancer. Six modules delivered online; participants complete flexibly over four weeks.
Treatment-As-Usual Control
Other interventionDigital information pack (PDF) signposting to existing UK cancer-support organisations and psychological resources. Distributed by email; no structured therapeutic program or study-specific content.
Treatment groups
Trial outcomes
Primary outcomes
Recruitment Rate
The feasibility of recruitment will be assessed by the number of participants enrolled in the study per month.
Intervention Adherence: Modules Accessed
The level of engagement with the Finding My Way-UK program, defined as the number of intervention modules accessed (opened) by each participant on the Finding My Way-UK platform.
Intervention Adherence: Modules Completed
The number of intervention modules completed by each participant on the Finding My Way-UK platform.
Retention Rate at Post-Intervention
Assessed by the percentage of participants who complete the post-intervention outcome assessment.
Secondary outcomes
Change from Baseline in Benefit Finding Score
Measured using the Benefit Finding Scale (BFS). The BFS contains 17 items rated from 1 = not at all to 5 = extremely, summed to a total score range of 17-85, with higher scores indicating greater benefit finding. Analyses will be descriptive and exploratory, focusing on estimating pre-post effect sizes and the proportion of participants showing reliable improvement using Reliable Change Indices; no formal hypothesis testing will be performed.
Change from Baseline in Satisfaction with Life
Subjective well-being will be assessed with the Satisfaction with Life Scale (SWLS). The SWLS comprises 5 items rated from 1 = strongly disagree to 7 = strongly agree, summed to give a total score range of 5-35, where higher scores reflect greater life satisfaction.
Change from Baseline in Hope
Measured using the Herth Hope Index (HHI). The HHI includes 12 items rated 1 = strongly disagree to 4 = strongly agree, summed for a total score range of 12-48; higher values indicate greater hope.
Change from Baseline in Resilience
Measured using the Connor-Davidson Resilience Scale-10 (CD-RISC-10). Ten items rated 0 (not true at all) to 4 (true nearly all the time) yield a total score range of 0-40, with higher scores indicating greater resilience.
Other outcomes
Change from Baseline in Self-Management Self-Efficacy
Measured using the Self-Efficacy for Managing Chronic Disease Scale. Six items rated 1-10; mean score represents overall self-efficacy (higher scores indicate higher self-management self-efficacy).
Information-Seeking Style
Assessed using the Cancer Information-Seeking Preferences Questionnaire, a single-item measure that classifies participants into one of five information-seeking styles: intense seekers, complementary seekers, fortuitous seekers, minimal/uninterested seekers, or guarded avoiders.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Edge Hill University
Lead sponsor
Flinders University
Collaborator
This trial is not recruiting at the moment. You can still explore other options: